Glucagon mini-dosing pen for treatment of hypoglycemia
Ended Project Grant Awarded Last action
- Award ID
- R44DK096715
- Recipient
-
Xeris Pharmaceuticals, Inc. UEI YAV5AK7VKJ31
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $1,130,725
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Place of performance
- Austin, TX 78705, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $451,756 | |
| Original award | $678,969 |
Quick answers
Who received award R44DK096715?
R44DK096715 was awarded to Xeris Pharmaceuticals, Inc. by National Institutes of Health (Department of Health and Human Services) on September 16, 2013.
How much is award R44DK096715 worth?
$1,130,725 has been obligated on R44DK096715.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award